APA (7th ed.) Citation

A, S., M, B., F, I., G, G., F, C., M, L., . . . M, B. (2025). Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies. Vaccines, 13(4), . https://doi.org/10.3390/vaccines13040419

Chicago Style (17th ed.) Citation

A, Sicuranza, et al. "Therapeutic Vaccinations with P210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies." Vaccines 13, no. 4 (2025). https://doi.org/10.3390/vaccines13040419.

MLA (9th ed.) Citation

A, Sicuranza, et al. "Therapeutic Vaccinations with P210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies." Vaccines, vol. 13, no. 4, 2025, https://doi.org/10.3390/vaccines13040419.